Search results for "cancer diagnosis"
Selected Filters:
Early detection of prostate cancer through game-changing molecular biomarkers
Dr. Nallasivam Palanisamy, Henry Ford Cancer Institute, discusses his discovery of the first pseudogene-associated recurrent gene fusion in cancer and the potential for this robust biomarker for application beyond prostate cancer
Analyzing cancer progression and treatment efficacy with imaging mass spectrometry
New trial to repurpose cancer drug for COVID-19 patients
The trial will study the use of ruxolitinib, a JAK inhibitor, to investigate its effect on reducing complications in deteriorating COVID-19 patients
Why HUB Organoids are key to advancing personalized cancer therapies
Dr. Sylvia Boj discusses the advantages of organoids and how these 3D tissue cultures have enormous potential to revolutionize how we treat patients and predict therapeutic response
Antibody-drug conjugates for anti-cancer therapy – your questions answered
Catch up on this on-demand webinar to learn how researchers at LifeArc are investigating a novel approach to targeting ALK-expressing neuroblastoma cells
Automating tumor-specific 3D cultures for anti-cancer drug screening
Join this webinar to find out how 3D cell culture overcomes the limitations of traditional 2D culture
Immunovia continues with next stage of the Lung Cancer Project
Immunovia will receive fresh blood samples from the pharmaceutical partner for analysis
Organoid library development: Testing patient sensitivity to potential cancer therapies
Discover how one lab is using patient-derived pancreatic organoids to deliver personalized treatments
Potential of whole genome sequencing to enable personalized cancer treatment
Study done at the University of Cambridge suggests a way to predict prognosis and most effective treatment in cancer
Nanomedicines and advanced therapeutics for gynecological cancers
Molecular Pathology Laboratory Network, Inc. selects HALO AP to deliver comprehensive reference laboratory services and biopharma laboratory support
AI-powered solution to enhance diagnostic efficiency, streamline clinical trials, and improve patient outcomes across global pathology networks
Can immune-microbiome profiling revolutionize leukemia care?
With cases rising among younger adults in India, researchers race to develop predictive diagnostics and immune-informed therapies
CLINICAL24: Pioneering sepsis care and management with Dr. Ron Daniels
Meet Dr. Ron Daniels, a #CLINICAL24 Ambassador, and discover his tireless fight to improve sepsis diagnostics and care
bioMérieux announces the CE marking of VIDAS tests for Chikungunya virus diagnosis
Based on single-sample testing the VIDAS Anti-CHIKUNGUNYA IgM and IgG are easy to use and accessible to all laboratories
Baby therapy boosts social development, reducing clinical autism diagnosis by two-thirds
These findings are the first evidence that a pre-emptive intervention during infancy could lead to a child falling below the threshold for a clinical diagnosis of autism
PCR or immunoassay? How to diagnose Ebola
QIAGEN and GENCURIX announce QIAcuity Digital PCR IVD assay development partnership
Partnership aims to broaden adoption of QIAcuityDx Four platform offering clinical diagnostic laboratories a range of clinical oncology assays
IBL International collaborates with Grifols on advanced biomarker panels
Grifols and IBL, a Tecan company, seek to revolutionize clinical diagnostics with a future high-sensitivity, multiplexed immunoassay platform